Pure steroidal antiestrogens or tamoxifen for breast cancer? Lynda Wiseman Newsletter Article 14 February 2013 Pages: 3 - 4
Progress towards vaccines for mucosal immunity Gill Higgins Newsletter Article 14 February 2013 Pages: 5 - 5
Necessary measures to control the use of high-cost drugs Greg Plosker Newsletter Article 14 February 2013 Pages: 8 - 8
Specific cytotoxicity with antibody-targetted RNases Newsletter Article 14 February 2013 Pages: 8 - 8
Have researchers found an immune booster for AIDS? Newsletter Article 14 February 2013 Pages: 15 - 15
Subtle differences between calcium antagonists and β-blockers after MI Newsletter Article 14 February 2013 Pages: 15 - 15
Gliatilin® improves function in multi-infarct dementia Newsletter Article 14 February 2013 Pages: 18 - 18
Ketorolac offers a possible alternative to morphine Newsletter Article 14 February 2013 Pages: 20 - 21
Low risk of severe reactions to hepatitis B vaccine Newsletter Article 14 February 2013 Pages: 21 - 21
Lipids not to blame in propofol-induced metabolic acidosis Newsletter Article 14 February 2013 Pages: 22 - 22
Previous streptokinase therapy may predispose to adverse urokinase effects Newsletter Article 14 February 2013 Pages: 22 - 22
‘Approve felbamate and gabapentin’ recommends FDA panel Newsletter Article 14 February 2013 Pages: 22 - 22